Value Bridge — TCHD D/B/A JPS HEALTH NETWORK
Current $-30M → Target $-17M (+$13.4M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-30.4M
Current EBITDA
$-17.0M
Target EBITDA
+$13.4M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$3.0M
Payer Mix Optimization
$7.3M
Cost to Collect Reduction
$2.4M
Clean Claim Improvement
$1.8M
Volume & Rate Growth
$12.2M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-30M to $-17M. The highest-impact lever is Volume & Rate Growth at $4.9M probability-weighted.
IC talking point: "We see $13M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $148M in equity value creation."